Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.57 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 9/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL287361 | 1.00 | FOLH1 (0.57) | FOLH1SLC6A5CA1CA2CA12 | |
| SCHEMBL30915497 | 1.00 | FOLH1 (0.57) | FOLH1SLC6A5CA1CA2CA12 | |
| SCHEMBL28151343 | 0.98 | FOLH1 (0.55) | FOLH1SLC6A5CA1CA2CA12 | |
| SCHEMBL28151347 | 0.98 | FOLH1 (0.55) | FOLH1SLC6A5CA1CA2CA12 | |
| SCHEMBL28151408 | 0.98 | FOLH1 (0.55) | FOLH1SLC6A5CA1CA2CA12 | |
| SCHEMBL29720838 | 0.98 | FOLH1 (0.55) | FOLH1SLC6A5CA1CA2CA12 | |
| SCHEMBL28151407 | 0.98 | FOLH1 (0.55) | FOLH1SLC6A5CA1CA2CA12 | |
| SCHEMBL6153373 | 0.95 | FOLH1 (0.50) | FOLH1SLC6A5CA1CA2CA12 | |
| SCHEMBL6153374 | 0.95 | FOLH1 (0.50) | FOLH1SLC6A5CA1CA2CA12 | |
| SCHEMBL6153376 | 0.95 | FOLH1 (0.50) | FOLH1SLC6A5CA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4211146-B1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | UNIV BAR ILAN (IL) | 2026-05-20 | — | — | EP | claimed |
| US-12616760-B2 | Synthetic cyclic peptide mimetics | BAR ILAN UNIVERSITY (IL) | 2026-05-05 | — | — | US | claimed |
| US-20260042739-A1 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | MANNKIND CORP (US) | 2026-02-12 | — | — | US | claimed |
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-26 | — | — | US | claimed |
| US-20250163003-A1 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2025-05-22 | — | — | US | claimed |
| CN-119591553-A | Diamino diketone application of piperazine compound | 上海昊海生物科技股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| EP-4493273-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | Politechnika Wroclawska (PL) | 2025-01-22 | — | — | EP | claimed |
| CN-118406439-B | Chemical mechanical polishing composition and application thereof in tungsten chemical mechanical polishing | 万华化学集团电子材料有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-118108617-B | Production process of trifluoroacetyl lysine | 山东极地医药科技有限公司 | 2024-10-15 | — | — | CN | claimed |
| US-20240316225-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | BAR ILAN UNIVERSITY (IL) | 2024-09-26 | — | — | US | claimed |
| US-20020183551-A1 | Process for the preparation of N-carboxyanhydrides | ISOCHEM (FR) | 2002-12-05 | — | — | US | claimed |
| EP-1262480-A1 | Process for the preparation of N-carboxyanhydrides of amino acids | ISOCHEM (FR) | 2002-12-04 | — | — | EP | claimed |
| US-6479665-B2 | REACTING ALPHA-, BETA- OR GAMMA- AMINO ACID OR OF ONE OF ITS SALTS WITH PHOSGENE, DIPHOSGENE AND/OR TRIPHOSGENE IN A SOLVENT MEDIUM, IN PRESENCE OF UNSATURATED ORGANIC COMPOUND WHICH HAS ONE OR MORE ETHYLENIC DOUBLE BONDS | ISOCHEM (FR) | 2002-11-12 | — | — | US | claimed |
| US-20020082431-A1 | Process for the preparation of N-carboxyanhydrides | ISOCHEM (FR) | 2002-06-27 | — | — | US | claimed |
| EP-1201659-A1 | Process for the preparation of N-carboxyanhydrides | ISOCHEM (FR) | 2002-05-02 | — | — | EP | claimed |
| EP-0517788-A1 | 19 F LABELLED COMPOUNDS AS NMR IMAGING AND SPECTROSCOPY AGENTS. | UNIV TEXAS (US) | 1992-12-16 | — | — | EP | claimed |
| WO-1991012824-A2 | 19F LABELLED COMPOUNDS AS NMR IMAGING AND SPECTROSCOPY AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-09-05 | — | — | WO | claimed |
| EP-0213996-B1 | RAMIFIED POLYMERS BASED ON LIPOPEPTIDES FORMING THERMOTROPIC AND LYOTROPIC LIQUID CRYSTALS, THEIR USE AND CORRESPONDING MONOMERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1989-09-06 | — | — | EP | claimed |
| EP-0239062-A2 | N2-(1-carboxy-3-oxo-3-phenylpropyl)-L-Lysine compounds and their derivatives | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-09-30 | — | — | EP | claimed |
| EP-0213996-A1 | Ramified polymers based on lipopeptides forming thermotropic and lyotropic liquid crystals, their use and corresponding monomers | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1987-03-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183551-A1 | Process for the preparation of N-carboxyanhydrides | NPEPPS, DDOST, DNPEP | FOLH1 279/4885SLC6A5 690/4885CA1 2401/4885 |
| US-20260042739-A1 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | ACMSD, DNPEP, PGM2 | FOLH1 1264/4885SLC6A5 76/4885CA1 428/4885 |
| US-20250163003-A1 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | PGM2, DNPEP, NPEPPS | FOLH1 1006/4885SLC6A5 355/4885CA1 243/4885 |
| US-12616760-B2 | Synthetic cyclic peptide mimetics | TPX2, IAPP, HAX1 | FOLH1 1510/4885SLC6A5 2249/4885CA1 208/4885 |
| US-20240316225-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | IAPP, QPCTL, DNPEP | FOLH1 701/4885SLC6A5 3038/4885CA1 304/4885 |
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | F11, F2, F12 | FOLH1 1307/4885SLC6A5 4823/4885CA1 674/4885 |
| US-20020082431-A1 | Process for the preparation of N-carboxyanhydrides | NPEPPS, CPN1, DDOST | FOLH1 431/4885SLC6A5 1676/4885CA1 3068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.